USC.edu
Are You a Patient?
Newsroom

Department of Cancer Biology

Journalist on Deadline?
Media Mention

NATURE ◆ The baby whose life was saved by the first personalized CRISPR therapy

December 08, 2025
Campus News

Medical and engineering teams’ work on brain tumors, leukemia are NEMO Prize winners

November 24, 2025
Group of healthcare professionals gathered around a laptop, actively collaborating
Media Mention

NATURE ◆ Personalized gene editing helped one baby: can it be rolled out widely?

October 31, 2025
Campus News

USC researchers pioneer lifesaving cancer breakthroughs

July 31, 2025
Heinz-Josef Lenz is in a laboratory wearing a white coat and talking to two individuals
Press Release

AAAS elects Keck School of Medicine of USC molecular biologist Yali Dou as 2025 fellow

March 27, 2025
Photo shows molecular biologist Yali Dou, PhD, from the Keck School of Medicine of USC.
Campus News

New Department of Cancer Biology, Keck School of Medicine

February 20, 2025
Close up of genomic sampling machine in laboratory.
Campus News

Keck School of Medicine celebrates faculty achievements at annual awards ceremony

October 29, 2024
Award recipients pose with Dean Meltzer
Press Release

USC researchers develop blood test for early-stage ovarian cancer

October 11, 2023
ovarian blood test slide
Press Release

Study finds new, unexpected mechanism of cancer cell spread

July 24, 2023
Researchers from the Keck School of Medicine of USC used imaging techniques to study how the protein GRP78 controls cancer cell behavior. In the top row, human lung cancer cells were engineered to over-express GRP78 in the nucleus. In the bottom row, cells lacked GRP78 in the nucleus. The green staining depicts the cytoskeletal protein F-actin which controls cell shape and motility and the blue staining depicts the nucleus. (Image courtesy of Ze Liu, Ph.D, and Amy Lee, PhD)
Press Release

Study shows how liver cancer hijacks circadian clock machinery inside cells

January 09, 2023
Pictured is an artist’s rendering of circadian clock proteins BMAL1 and CLOCK influencing hepatocellular carcinoma (HCC) cell proliferation. The study shows that in humans, HCC cells rely on BMAL1 and CLOCK for sustained cell growth. Targeting clock proteins provides a new pathway to develop novel cancer therapies. (Image: Julia E. Fletcher-Selway, JEFS Storytelling Arts)
  • 1
  • 2